Maha Hussain Joins the Lurie Cancer Center
Named Associate Director for Clinical Sciences Research
Internationally renowned clinical researcher, Maha H. Hussain, MD, will join the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as the Associate Director for Clinical Sciences Research. Hussain will also serve as Co-Director of the Lurie Cancer Center’s Genitourinary Oncology Program, along with Edward Schaeffer, MD, PhD, Chair of the Department of Urology at Northwestern University Feinberg School of Medicine.
Dr. Hussain’s research efforts are focused on the development of novel therapeutics integrating scientific advances into clinical trials for prostate and bladder cancer. She is currently Cis-Maisel Professor of Oncology, and Professor of Medicine and Urology at the University of Michigan. She has served in many scientific and leadership roles at the University of Michigan including Associate Director for Clinical Research and Co-Leader of the Prostate Cancer/GU Oncology Program at the UM Comprehensive Cancer Center, as well as Associate Chief for Clinical Research in the Division of Hematology/Oncology.
As Associate Director for Clinical Sciences Research, Hussain will oversee the development and coordination of the Lurie Cancer Center’s established clinical sciences research programs and working groups, and foster interdisciplinary and inter-programmatic collaborations. She will join Northwestern on September 1, 2016.
“We are thrilled to welcome Maha to the Lurie Cancer Center,” said Director Leonidas Platanias, MD, PhD. “She is one of the world’s leading researchers in the field of prostate cancer and her presence will strengthen our clinical research efforts immensely.”
Dr. Hussain’s extensive national scientific leadership roles include serving as Co-Chair of the Prostate Cancer Subcommittee/Genitourinary Cancer Committee of SWOG, where she guided research in areas of advanced prostate cancer that led to changing standards of care. She has served as a member and chair of the Integration Panel of the U.S. Army Medical Research and Materiel Command Prostate Cancer Research Program, and as a member and Chair of the U.S. Food and Drug Administration Oncology Drug Advisory Committee. Hussain has held numerous leadership roles within the American Society of Clinical Oncology (ASCO) and was recently elected to ASCO’s Board of Directors which is comprised of oncology leaders from various specialties. She currently serves on ASCO’s Clinical Practice Guidelines Committee, as a member of the National Comprehensive Cancer Network (NCCN) International Committee and the Advanced Prostate Cancer Panel of the American Urological Association.